Latest Burford Quarterly explores key trends driving innovation in commercial disputes in 2025
Burford Capital has released its first Quarterly journal of 2025, focusing on innovative financial strategies in commercial disputes. The publication explores how businesses and law firms are transforming their approach to legal finance, including alternative billing structures and IP asset monetization.
The Quarterly features articles on legal finance innovation for law firms, healthcare antitrust opt-outs with focus on the upcoming March 2025 Blue Cross Blue Shield antitrust class actions deadline, IP potential in life sciences, and perspectives on international arbitration in London. The articles discuss how legal finance helps firms solve challenges, accelerate growth, and mitigate financial strain in high-cost litigation.
According to Aviva Will, President of Burford Capital, legal finance serves as a catalyst for innovation in the legal industry by providing capital, mitigating risk, and removing barriers for business growth.
Burford Capital ha pubblicato il suo primo Journal Trimestrale del 2025, incentrato su strategie finanziarie innovative nelle controversie commerciali. La pubblicazione esplora come le aziende e gli studi legali stiano trasformando il loro approccio alla finanza legale, incluse le strutture di fatturazione alternative e la monetizzazione degli asset IP.
Il trimestrale presenta articoli sull'innovazione nella finanza legale per gli studi legali, le esclusioni antitrust nel settore sanitario con un focus sulla prossima scadenza per le azioni collettive antitrust di Blue Cross Blue Shield prevista per marzo 2025, il potenziale IP nelle scienze della vita e le prospettive sull'arbitrato internazionale a Londra. Gli articoli discutono di come la finanza legale aiuti gli studi a risolvere le sfide, accelerare la crescita e mitigare la pressione finanziaria in contenziosi ad alto costo.
Secondo Aviva Will, Presidente di Burford Capital, la finanza legale funge da catalizzatore per l'innovazione nell'industria legale, fornendo capitale, mitigando i rischi e rimuovendo le barriere per la crescita delle imprese.
Burford Capital ha lanzado su primer Journal Trimestral de 2025, centrado en estrategias financieras innovadoras en disputas comerciales. La publicación explora cómo las empresas y los despachos de abogados están transformando su enfoque hacia las finanzas legales, incluyendo estructuras de facturación alternativas y la monetización de activos de propiedad intelectual.
El trimestral presenta artículos sobre innovación en finanzas legales para despachos de abogados, exclusiones antimonopolio en salud con enfoque en la próxima fecha límite de acciones colectivas antimonopolio de Blue Cross Blue Shield en marzo de 2025, el potencial de propiedad intelectual en ciencias de la vida, y perspectivas sobre arbitraje internacional en Londres. Los artículos discuten cómo las finanzas legales ayudan a las firmas a resolver desafíos, acelerar el crecimiento y mitigar la presión financiera en litigios de alto costo.
Según Aviva Will, Presidenta de Burford Capital, las finanzas legales sirven como un catalizador para la innovación en la industria legal al proporcionar capital, mitigar riesgos y eliminar barreras para el crecimiento empresarial.
버포드 캐피탈은 2025년 첫 분기 보고서를 발표하였으며, 상업 분쟁에 대한 혁신적인 재무 전략에 중점을 두고 있습니다. 이 출판물은 기업과 법률 사무소가 법적 금융 접근 방식을 어떻게 변화시키고 있는지 탐구하며, 대체 청구 구조 및 지적 재산 자산의 수익화 등을 포함합니다.
이번 분기 보고서는 법률 사무소를 위한 법적 금융 혁신, 2025년 3월로 예정된 블루 크로스 블루 쉴드의 독점 금지 집단 소송 기한에 집중한 의료 분야의 독점 금지 제외 사항, 생명 과학 분야의 지적 재산 잠재력, 런던의 국제 중재에 대한 관점에 관한 기사를 포함하고 있습니다. 이 기사들은 법적 금융이 기업이 문제를 해결하고, 성장을 가속화하며, 고비용 소송에서 재정적 압박을 완화하는 데 어떻게 도움을 주는지를 논의합니다.
아비바 윌 버포드 캐피탈 사장은 법적 금융이 혁신을 촉진하는 역할을 한다고 말하며, 자본을 제공하고, 위험을 완화하며, 기업 성장을 위한 장벽을 제거한다고 강조했습니다.
Burford Capital a publié son premier Journal Trimestriel de 2025, axé sur des stratégies financières innovantes dans les litiges commerciaux. La publication explore comment les entreprises et les cabinets d'avocats transforment leur approche du financement juridique, y compris des structures de facturation alternatives et la monétisation des actifs de propriété intellectuelle.
Le trimestriel propose des articles sur l'innovation dans le financement juridique pour les cabinets d'avocats, les exceptions antitrust dans le secteur de la santé avec un accent sur la prochaine échéance des actions collectives antitrust de Blue Cross Blue Shield prévue en mars 2025, le potentiel de la propriété intellectuelle dans les sciences de la vie et les perspectives sur l'arbitrage international à Londres. Les articles discutent de la manière dont le financement juridique aide les cabinets à résoudre des défis, à accélérer leur croissance et à atténuer la pression financière dans des litiges coûteux.
Selon Aviva Will, Présidente de Burford Capital, le financement juridique agit comme un catalyseur d'innovation dans l'industrie juridique en fournissant du capital, en atténuant les risques et en supprimant les obstacles à la croissance des entreprises.
Burford Capital hat sein erstes Quartalsjournal für 2025 veröffentlicht, das sich auf innovative Finanzstrategien in kommerziellen Streitigkeiten konzentriert. Die Veröffentlichung untersucht, wie Unternehmen und Anwaltskanzleien ihren Ansatz zur Rechtsfinanzierung verändern, einschließlich alternativer Abrechnungsstrukturen und der Monetarisierung von IP-Vermögenswerten.
Das Quartalsjournal enthält Artikel über Innovationen in der Rechtsfinanzierung für Anwaltskanzleien, Antitrust-Ausnahmen im Gesundheitswesen mit dem Fokus auf die bevorstehende Frist für die Antitrust-Kollektivklagen von Blue Cross Blue Shield im März 2025, das IP-Potenzial in den Lebenswissenschaften und Perspektiven zur internationalen Schiedsgerichtsbarkeit in London. Die Artikel diskutieren, wie die Rechtsfinanzierung den Kanzleien hilft, Herausforderungen zu lösen, das Wachstum zu beschleunigen und finanzielle Belastungen in kostenintensiven Rechtsstreitigkeiten zu mildern.
Laut Aviva Will, Präsidentin von Burford Capital, fungiert die Rechtsfinanzierung als Katalysator für Innovationen in der Rechtsbranche, indem sie Kapital bereitstellt, Risiken mindert und Barrieren für das Unternehmenswachstum abbaut.
- Publication demonstrates Burford's thought leadership in legal finance industry
- Strategic focus on high-value sectors including healthcare and life sciences
- Expansion of services into IP asset monetization and healthcare litigation funding
- None.
Insights
The latest Burford Quarterly publication represents a standard marketing initiative to showcase the company's thought leadership, without containing material financial information or business updates that would impact stock valuation. While the publication discusses important industry trends like healthcare antitrust opt-outs and IP monetization in life sciences, these are educational pieces rather than announcements of new business developments or financial performance.
The content appears designed to reinforce Burford's market position and educate potential clients about litigation funding opportunities, but does not disclose any new deals, financial metrics, or material changes to business strategy. From an investor perspective, this type of regular industry publication serves primarily as a marketing and brand-building tool rather than market-moving news.
This Burford Quarterly examines the innovative ways in which businesses and law firms are reimagining their financial strategies around commercial disputes. Examples of this include law firms using creative billing structures as alternatives to hourly fees; companies choosing to opt out of litigation to maximize and accelerate recoveries; or businesses monetizing IP assets, allowing for continued investment in other vital areas of the business.
Articles in the Burford Quarterly No.1 2025 include:
- The innovation engine: Legal finance for forward-thinking law firms
As law firms launch into 2025, a year that promises continued disruption and opportunity, innovation is not a choice—it's an imperative. Forward-thinking firms are reimagining their financial strategies, moving beyond traditional models to embrace legal finance as a critical tool for transformation. In this article, Travis Lenkner and Emily Slater explore innovative ways legal finance is helping firms solve pressing challenges and accelerate growth.
- Healthcare antitrust opt-outs: Improving liquidity by monetizing valuable legal claims
An increasing number of healthcare businesses are recognizing the value that legal finance provides in helping to mitigate the financial strain of high-cost litigation and expedite recoveries in high-stakes litigation. Ahead of a March 2025 opt-out deadline for claimants in the Blue Cross Blue Shield (BCBS) antitrust class actions, Charles Griffin summarizes insights from a recent webcast in which experts from Burford and Paul Hastings presented factors hospital networks and providers should consider in weighing their options.
- Legal finance and life sciences: Unlocking IP potential in pharma, biotech and medical devices
Innovation inEurope's life sciences and pharmaceutical sectors is vital, but long R&D cycles and short profit windows pose challenges. Joshua Harris explains how legal finance helps companies protect and monetize IP assets, enabling continued investment in life-saving technologies.
- International arbitration in
London : Next-Gen leaders' perspective
Geoff Nicholas, Christiane Deniger and James MacKinnon lead a Burford roundtable withLondon -based arbitration lawyers. Partners from A&O Shearman, Debevoise & Plimpton, Bryan Cave Leighton Paisner and Freshfields share their insights on key trends and challenges shaping international arbitration, including the use of technology and AI and arbitral efficiency.
Aviva Will, President of Burford Capital, says: "While the legal industry may be slow to evolve, legal finance is a powerful tool to drive innovation in the business of law. This issue of the Burford Quarterly highlights key trends in commercial litigation and arbitration in 2025 and shows how litigation funding continues to shape the legal industry. By providing capital and mitigating risk, funding removes barriers for businesses and facilitates growth, and the latest Quarterly brings insights, analysis and real-world examples of tools to help business executives, GCs, CLOs and law firm attorneys recognize and harness the full potential of finance for law."
About Burford Capital
Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its offices in
For more information, please visit www.burfordcapital.com.
This announcement does not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.
View original content to download multimedia:https://www.prnewswire.com/news-releases/latest-burford-quarterly-explores-key-trends-driving-innovation-in-commercial-disputes-in-2025-302353384.html
SOURCE Burford Capital
FAQ
What key trends does Burford Capital (BUR) identify for legal finance in 2025?
What is the significance of the March 2025 deadline mentioned in Burford's (BUR) Quarterly?
How is Burford Capital (BUR) addressing innovation in the life sciences sector?
What solutions does Burford Capital (BUR) offer for law firms in 2025?
